| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-14 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-13 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |